| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neuropace Inc (NPCE) has 12 insiders with recent SEC Form 4 filings, including 5 buys and 10 sells. NPCE is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.24M | $62.82M | - | |
| Dir | 593.4K | $11.51M | - | |
| CFO | 131.6K | $2.55M | - | |
| CEO | 103.1K | $2.00M | - | |
| Other | 78.7K | $1.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2023 | Morrell Martha59 | Chief Medical Officer | Sell | 11,005 | $8.16 | $89,773.29 | -8.0% | +72.7% | +37.2% | |
| Dec 1, 2023 | Kck Ltd. | 10% Owner | Sell | 16,167 | $8.78 | $141,882.49 | - | +81.7% | +19.1% | |
| Nov 28, 2023 | Kck Ltd. | 10% Owner | Sell | 11,171 | $8.87 | $99,109.15 | - | +93.7% | +17.1% | |
| Oct 3, 2023 | Orbimed Advisors LLC67 | 10% Owner | Sell | 8,314 | $9.07 | $75,449.12 | -0.1% | +16.3% | -17.6% | |
| Nov 22, 2022 | Accelmed Partners II L.P.52 | 10% Owner | Buy | 390,291 | $1.50 | $585,046.21 | +4.6% | +256.0% | +479.3% | |
| Jun 8, 2022 | Ridley Irina46 | General Counsel And Secretary | Sell | 2,500 | $5.78 | $14,445.00 | -3.9% | -17.2% | -27.2% | |
| Feb 28, 2022 | Ridley Irina46 | General Counsel And Secretary | Sell | 1,470 | $7.54 | $11,081.74 | -18.1% | -20.1% | -34.2% | |
| Apr 21, 2021 | Garfield Greg Shaw | Director | Buy | 13,235 | $17.00 | $224,995.00 | +51.7% | -5.8% | -66.5% | |
| Apr 21, 2021 | Orbimed Advisors LLC67 | 10% Owner | Buy | 235,000 | $17.00 | $3,995,000.00 | New | -5.8% | -66.5% | |
| Apr 21, 2021 | Accelmed Partners II L.P.52 | 10% Owner | Buy | 588,235 | $17.00 | $9,999,995.00 | New | -5.8% | -66.5% |